Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 3NIH 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Prostatic Neoplasms 5Breast Neoplasms 5Sarcoma 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Carcinoma, Renal Cell 3Wilms Tumor 2Unspecified Adult Solid Tumor, Protocol Specific 2Testicular Neoplasms 2Teratoma 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Kidney Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Burkitt Lymphoma 2Breast Neoplasms, Male 2Astrocytoma 2

Interventions

Irinotecan 15Gemcitabine 14Paclitaxel 13Cisplatin 13alvocidib 11Oxaliplatin 9Fluorouracil 9Taxes 7Leucovorin 7Carboplatin 7Bortezomib 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7tanespimycin 5Vorinostat 5Early Intervention, Educational 57-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine 4Topotecan 3Sorafenib 3Doxorubicin 3Docetaxel 3Capecitabine 3Bevacizumab 37-hydroxystaurosporine 3temsirolimus 2sargramostim 2ixabepilone 2eribulin 2aldesleukin 2VNP 20009 2Trastuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Unspecified Adult Solid Tumor, Protocol Specific × ixabepilone × Clear all
NCT00028561 2013-01-17

BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Terminated
45 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00043095 2008-07-24

BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡